Intriguingly, as the therapeutic effect of CXCR3 inhibition was compromised in mice depleted of NK cells or with mutations in IFN-γ, it has been suggested that the role of CXCR3 is not simply to mediate tumor cell trafficking but also to support antitumor immunity [37]. Here, CXCR3 is linked to neoplasm.